Body

Genetic mutation found to cause ovarian failure

Premature ovarian failure, also known as primary ovarian insufficiency (POI), affects 1% of all women worldwide. In most cases, the exact cause of the condition, which is often associated with infertility, is difficult to determine.

Short-necked Triassic marine reptile discovered in China

A new species of short-necked marine reptile from the Triassic period has been discovered in China, according to a study published December 17, 2014 in the open-access journal PLOS ONE by Xiao-hong Chen from Wuhan Centre of China Geological Survey and colleagues.

Stem cells faulty in Duchenne muscular dystrophy, Stanford researchers find

Like human patients, mice with a form of Duchenne muscular dystrophy undergo progressive muscle degeneration and accumulate connective tissue as they age. Now, researchers at the Stanford University School of Medicine have found that the fault may lie at least partly in the stem cells that surround the muscle fibers.

Dutch barnacle geese have more active immune system than same species in the North

Bird migration is an impressive phenomenon, but why birds often travel huge distances to and from their breeding grounds in the far North is still very unclear. Suggestions include that the birds profit from longer daylight hours, or that there are fewer predators. Researchers from the University of Groningen and the NIOO-KNAW Vogeltrekstation, the Dutch centre for bird migration and demographics, have discovered a new explanation.

Multiple allergic reactions traced to single protein

Johns Hopkins and University of Alberta researchers have identified a single protein as the root of painful and dangerous allergic reactions to a range of medications and other substances. If a new drug can be found that targets the problematic protein, they say, it could help smooth treatment for patients with conditions ranging from prostate cancer to diabetes to HIV. Their results appear in the journal Nature on Dec. 17.

Study identifies 53 approved drugs that may block Ebola infection

Researchers found 53 existing drugs that may keep the Ebola virus from entering human cells, a key step in the process of infection, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai and the National Institutes of Health (NIH), and published today in the Nature Press journal Emerging Microbes and Infections.

Study shows how breast cancer cells break free to spread in the body

More than 90 percent of cancer-related deaths are caused by the spread of cancer cells from their primary tumor site to other areas of the body. A new study has identified how one important gene helps cancer cells break free from the primary tumor.

A gene normally involved in the regulation of embryonic development can trigger the transition of cells into more mobile types that can spread without regard for the normal biological controls that restrict metastasis, the new study shows.

Contrasting views of kin selection assessed

In an article to be published in the January issue of BioScience, two philosophers tackle one of the most divisive arguments in modern biology: the value of the theory of "kin selection."

Unpacking brain damage in ALS

(PHILADELPHIA) - Researchers look to understand the causes of amyotrophic lateral sclerosis (ALS), in the hope of finding new ways to treat the disease. A new study published online today (December 17th) in the Cell Press journal Neuron shows that a common gene mutation in ALS generates a deadly protein that may cause the damage in the brain that leads to ALS.

Genetic variations associated with traits underlying type 2 diabetes in Mexican-Americans

WINSTON-SALEM, N.C. - Dec. 17, 2014 - While people of Mexican ancestry are nearly twice as likely to develop Type 2 diabetes as people of European heritage, the majority of research in this area has focused on those of European origin.

In an effort to understand why Mexicans are disproportionately affected by the disease, researchers at Wake Forest Baptist Medical Center led the largest study to date to examine the underlying causes. The study is published in the Dec. 17 issue of Diabetes.

New class of synthetic molecules mimics antibodies

New Haven, Conn. - A Yale University lab has crafted the first synthetic molecules that have both the targeting and response functions of antibodies.

The new molecules -- synthetic antibody mimics (SyAMs) -- attach themselves simultaneously to disease cells and disease-fighting cells. The result is a highly targeted immune response, similar to the action of natural human antibodies.

A new strategy for developing drugs to fight cancer and other diseases

Promising treatments known as biologics are on the market and under development for many serious illnesses such as cancer, but some of them come with high risks, even lethal ones. Now scientists have produced a novel class of molecules that could be as effective but without the dangerous side effects. They report their work on these compounds, which they tested on prostate cancer cells, in ACS' Journal of the American Chemical Society.

Heat boosts phthalate emissions from vinyl crib mattress covers

The U.S. continues to look at the use and regulation of phthalates, which have been associated with health problems. Of particular concern is the safety of these plastic additives to children. A new study aims to improve our understanding of one possible exposure route for babies: vinyl crib mattress covers. Scientists report in ACS' Environmental Science & Technology that as these covers warm up, they emit more phthalates into the air.

New Notre Dame paper offers novel insights into pathogen behavior

A new study by a team of researchers that includes University of Notre Dame scientists Joshua Shrout and Mark Alber provides new insights into the behavior of an important bacterial pathogen.

Alber, Vincent J. Duncan Family Professor of Applied Mathematics, and Schrout, an associate professor of civil and environmental engineering and earth sciences, studied Pseudomonas aeruginosa, an opportunistic pathogen responsible for both acute and persistent infections.

Not just for the holidays, mistletoe could fight obesity-related liver disease

Mistletoe hanging in doorways announces that the holidays are just around the corner. For some people, however, the symbolic plant might one day represent more than a kiss at Christmas time: It may mean better liver health. Researchers have found that a compound produced by a particular variety of the plant can help fight obesity-related liver disease in mice. Their study appears in ACS' Journal of Agricultural and Food Chemistry.